Hemant Roy, MD, will be named the first Franz J. Inglefinger, MD, Professor in Gastroenterology at an installation ceremony at 3 p.m. Thursday, July 20, in the Wilkins Board Room. The professorship, established by the Evans Medical Foundation in 2016, recognizes the enduring impact of Dr. Ingelfinger (1910-1980) on the field of gastroenterology and the Department of Medicine at BUSM.
Roy joined the community in 2013 as professor of medicine and chief of the Section of Gastroenterology at Boston Medical Center and BUSM. Prior to his arrival at BMC/BUSM, he was Duckworth Professor of Cancer Research, Director of Research and Vice Chair of Northshore University Health System and Clinical Associate Professor of Medicine at the University of Chicago Pritzker School of Medicine. He received his undergraduate degree from Vanderbilt University, summa cum laude, in molecular biology, and his MD with distinction from Northwestern University Medical School. He completed his clinical training in internal medicine at Beth Israel Deaconess Medical Center and a gastroenterology fellowship at University of Chicago.
A physician-scientist, Roy’s research interests focus on GI cancer risk stratification via detection of field carcinogenesis focusing on developing and implementing novel imaging technologies. He has more than 10 patents to aid in the commercialization of these fundamental advances. A recognized expert in cancer biomarkers, Roy is a recipient of numerous NIH grants for colon, pancreas, lung and prostate cancer, has more than 100 publications and serves on the NIH Cancer Biomarker Study Section. His clinical interests surround colon cancer syndromes and the role of gender in colorectal cancer screening.